logo
Plus   Neg
Share
Email

TransDigm Group Issues FY20 Outlook Below View- Quick Facts

While reporting its fourth-quarter financial results on Tuesday, TransDigm Group Inc. (TDG) forecast fiscal 2020 adjusted earnings in a range of $19.80 to $21.20 per share, compared with $18.27 per share in fiscal 2019.

The company also projects full-year sales in a range of $6.175 billion to $6.325 billion, compared with $5.223 billion in fiscal 2019.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $21.25 per share for the year on revenues of $6.34 billion. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT